{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T02:23:41Z","timestamp":1787192621443,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["Comit\u00e9 17"],"award-info":[{"award-number":["Comit\u00e9 17"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["Comit\u00e9 16 et 17"],"award-info":[{"award-number":["Comit\u00e9 16 et 17"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009468","name":"Conseil R\u00e9gional Aquitaine","doi-asserted-by":"publisher","award":["APPR2022-2022-17539310"],"award-info":[{"award-number":["APPR2022-2022-17539310"]}],"id":[{"id":"10.13039\/501100009468","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009468","name":"Conseil R\u00e9gional Aquitaine","doi-asserted-by":"publisher","award":["Oligovect project"],"award-info":[{"award-number":["Oligovect project"]}],"id":[{"id":"10.13039\/501100009468","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-21-CE44-0004"],"award-info":[{"award-number":["ANR-21-CE44-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-CE18-0028, Project NANOLIGO"],"award-info":[{"award-number":["ANR-22-CE18-0028, Project NANOLIGO"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-123238OB-I00"],"award-info":[{"award-number":["PID2021-123238OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CNS2023-143944, RYC2020-030241-I, PID2022-142842OB-I00"],"award-info":[{"award-number":["CNS2023-143944, RYC2020-030241-I, PID2022-142842OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["Elkartek 2024 Program (bmG24) ; Grant no. 2022333041"],"award-info":[{"award-number":["Elkartek 2024 Program (bmG24) ; Grant no. 2022333041"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003989","name":"Ikerbasque, Basque Foundation for Science","doi-asserted-by":"publisher","award":["CIVP21S13151"],"award-info":[{"award-number":["CIVP21S13151"]}],"id":[{"id":"10.13039\/501100003989","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04651-4","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T05:55:31Z","timestamp":1781416531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antitumoral activities of \u03bb\u2011carrageenan oligosaccharide- based nanoparticles"],"prefix":"10.1186","volume":"24","author":[{"given":"Jennifer","family":"Saliba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Porta Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Miranda-Perez de Alejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachida","family":"Mersni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhize","family":"Urkola-Arsuaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Musnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Cherfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"S\u00e1nchez-T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Maugard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Biard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Baranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Trinh Le Vi Kieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Gigoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00f9s","family":"Ruiz-Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Fruitier-Arnaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Carregal-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Groult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"key":"4651_CR1","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.3390\/ijms23095253","volume":"23","author":"A-G Niculescu","year":"2022","unstructured":"Niculescu A-G, Grumezescu AM. Novel Tumor-Targeting Nanoparticles for Cancer Treatment\u2014A Review. Int J Mol Sci Multidisciplinary Digit Publishing Inst. 2022;23:5253. https:\/\/doi.org\/10.3390\/ijms23095253.","journal-title":"Int J Mol Sci Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","volume":"16","author":"S Gavas","year":"2021","unstructured":"Gavas S, Quazi S, Karpi\u0144ski TM. Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Res Lett. 2021;16:173. https:\/\/doi.org\/10.1186\/s11671-021-03628-6.","journal-title":"Nanoscale Res Lett"},{"key":"4651_CR3","doi-asserted-by":"publisher","unstructured":"Madamsetty VS, Mukherjee A, Mukherjee S. Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics. Front Pharmacol [Internet]. Frontiers; 2019 [cited 2025 May 2];10. https:\/\/doi.org\/10.3389\/fphar.2019.01264","DOI":"10.3389\/fphar.2019.01264"},{"key":"4651_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/molecules25030715","volume":"25","author":"P de la Torre","year":"2020","unstructured":"de la Torre P, P\u00e9rez-Lorenzo MJ, Alc\u00e1zar-Garrido \u00c1, Flores AI. Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments. Molecules Multidisciplinary Digit Publishing Inst. 2020;25:715. https:\/\/doi.org\/10.3390\/molecules25030715.","journal-title":"Molecules Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell Elsevier. 2023;41:374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell Elsevier"},{"key":"4651_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7150\/ntno.34921","volume":"3","author":"D Reichel","year":"2019","unstructured":"Reichel D, Tripathi M, Butte P, Saouaf R, Perez JM. Tumor-activatable clinical nanoprobe for cancer imaging. Nanotheranostics. 2019;3:196\u2013211. https:\/\/doi.org\/10.7150\/ntno.34921.","journal-title":"Nanotheranostics"},{"key":"4651_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","volume":"6","author":"Q Duan","year":"2020","unstructured":"Duan Q, Zhang H, Zheng J, Zhang L. Turning Cold into Hot: Firing up the Tumor Microenvironment. Trends Cancer Elsevier. 2020;6:605\u201318. https:\/\/doi.org\/10.1016\/j.trecan.2020.02.022.","journal-title":"Trends Cancer Elsevier"},{"key":"4651_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12951-022-01476-9","volume":"20","author":"GSR Raju","year":"2022","unstructured":"Raju GSR, Pavitra E, Varaprasad GL, Bandaru SS, Nagaraju GP, Farran B, et al. Nanoparticles mediated tumor microenvironment modulation: current advances and applications. J Nanobiotechnol. 2022;20:274. https:\/\/doi.org\/10.1186\/s12951-022-01476-9.","journal-title":"J Nanobiotechnol"},{"key":"4651_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40824-018-0132-z","volume":"22","author":"S Uthaman","year":"2018","unstructured":"Uthaman S, Huh KM, Park I-K. Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications. Biomater Res Am Association Advancement Sci. 2018;22:22. https:\/\/doi.org\/10.1186\/s40824-018-0132-z.","journal-title":"Biomater Res Am Association Advancement Sci"},{"key":"4651_CR10","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41563-019-0503-4","volume":"18","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, Zhang J, Qi X, Li S, Liu G, Siddhanta S, et al. Furin-mediated intracellular self-assembly of olsalazine nanoparticles for enhanced magnetic resonance imaging and tumour therapy. Nat Mater Nat Publishing Group. 2019;18:1376\u201383. https:\/\/doi.org\/10.1038\/s41563-019-0503-4.","journal-title":"Nat Mater Nat Publishing Group"},{"key":"4651_CR11","doi-asserted-by":"publisher","first-page":"2202063","DOI":"10.1002\/adhm.202202063","volume":"12","author":"R Cheng","year":"2023","unstructured":"Cheng R, Santos HA. Smart Nanoparticle-Based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy. Adv Healthc Mater. 2023;12:2202063. https:\/\/doi.org\/10.1002\/adhm.202202063.","journal-title":"Adv Healthc Mater"},{"key":"4651_CR12","doi-asserted-by":"publisher","first-page":"138678","DOI":"10.1016\/j.ijbiomac.2024.138678","volume":"290","author":"DD Chakraborty","year":"2025","unstructured":"Chakraborty DD, Chakraborty P, Mondal A. An insight into cancer nanomedicine based on polysaccharides. Int J Biol Macromol. 2025;290:138678. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138678.","journal-title":"Int J Biol Macromol"},{"key":"4651_CR13","doi-asserted-by":"publisher","first-page":"69869","DOI":"10.1039\/C6RA10716H","volume":"6","author":"X Qi","year":"2016","unstructured":"Qi X, Wei W, Li J, Zuo G, Hu X, Zhang J, et al. Development of novel hydrogels based on Salecan and poly(N-isopropylacrylamide-co-methacrylic acid) for controlled doxorubicin release. RSC Adv Royal Soc Chem. 2016;6:69869\u201381. https:\/\/doi.org\/10.1039\/C6RA10716H.","journal-title":"RSC Adv Royal Soc Chem"},{"key":"4651_CR14","doi-asserted-by":"publisher","unstructured":"Zhu Y, Liu Y, Jin K, Pang Z. 13 - Polysaccharide nanoparticles for cancer drug targeting. In: Maiti S, Jana S, editors. Polysacch Carr Drug Deliv [Internet]. Woodhead Publishing; 2019. pp. 365\u201396. [cited 2025 May 2]. https:\/\/doi.org\/10.1016\/B978-0-08-102553-6.00013-1.","DOI":"10.1016\/B978-0-08-102553-6.00013-1"},{"key":"4651_CR15","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1016\/j.bioactmat.2021.03.008","volume":"6","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Xiang Y, Sheng R, Tom\u00e1s H, Rodrigues J, Gu Z, et al. Polysaccharide-based nanomedicines for cancer immunotherapy: A review. Bioact Mater. 2021;6:3358\u201382. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.03.008.","journal-title":"Bioact Mater"},{"key":"4651_CR16","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1021\/jf070183+","volume":"55","author":"H Chen","year":"2007","unstructured":"Chen H, Yan X, Lin J, Wang F, Xu W. Depolymerized products of lambda-carrageenan as a potent angiogenesis inhibitor. J Agric Food Chem. 2007;55:6910\u20137. https:\/\/doi.org\/10.1021\/jf070183+.","journal-title":"J Agric Food Chem"},{"key":"4651_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/md21050295","volume":"21","author":"C Manseur","year":"2023","unstructured":"Manseur C, Groult H, Porta M, Bodet P-E, Mersni-Achour R, Petit R, et al. A Screening Approach to Assess the Impact of Various Commercial Sources of Crude Marine \u03bb-Carrageenan on the Production of Oligosaccharides with Anti-heparanase and Anti-migratory Activities. Mar Drugs Multidisciplinary Digit Publishing Inst. 2023;21:295. https:\/\/doi.org\/10.3390\/md21050295.","journal-title":"Mar Drugs Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR18","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3390\/nu15092044","volume":"15","author":"M Tang","year":"2023","unstructured":"Tang M, Zhai L, Chen J, Wang F, Chen H, Wu W. The Antitumor Potential of \u03bb-Carrageenan Oligosaccharides on Gastric Carcinoma by Immunomodulation. Nutrients. Multidisciplinary Digit Publishing Inst. 2023;15:2044. https:\/\/doi.org\/10.3390\/nu15092044.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR19","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1021\/acs.biomac.4c01747","volume":"26","author":"M Porta-Zapata","year":"2025","unstructured":"Porta-Zapata M, Carregal-Romero S, Saliba J, Urkola-Arsuaga A, Miranda Perez de Alejo CB, Orue I, et al. Synthesis and Characterization of \u03bb-Carrageenan Oligosaccharide-Based Nanoparticles: Applications in MRI and In Vivo Biodistribution Studies. Biomacromolecules Am Chem Soc. 2025;26:1948\u201367. https:\/\/doi.org\/10.1021\/acs.biomac.4c01747.","journal-title":"Biomacromolecules Am Chem Soc"},{"key":"4651_CR20","doi-asserted-by":"publisher","first-page":"11062","DOI":"10.1038\/srep11062","volume":"5","author":"M Luo","year":"2015","unstructured":"Luo M, Shao B, Nie W, Wei X-W, Li Y-L, Wang B-L, et al. Antitumor and Adjuvant Activity of \u03bb-carrageenan by Stimulating Immune Response in Cancer Immunotherapy. Sci Rep. 2015;5:11062. https:\/\/doi.org\/10.1038\/srep11062.","journal-title":"Sci Rep"},{"key":"4651_CR21","doi-asserted-by":"publisher","first-page":"16405","DOI":"10.1039\/D1NR04964J","volume":"13","author":"S Haque","year":"2021","unstructured":"Haque S, Tripathy S, Ranjan Patra C. Manganese-based advanced nanoparticles for biomedical applications: future opportunity and challenges. Nanoscale Royal Soc Chem. 2021;13:16405\u201326. https:\/\/doi.org\/10.1039\/D1NR04964J.","journal-title":"Nanoscale Royal Soc Chem"},{"key":"4651_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/md17030140","volume":"17","author":"H Groult","year":"2019","unstructured":"Groult H, Cousin R, Chot-Plassot C, Maura M, Bridiau N, Piot J-M, et al. \u03bb-Carrageenan Oligosaccharides of Distinct Anti-Heparanase and Anticoagulant Activities Inhibit MDA-MB-231 Breast Cancer Cell Migration. Mar Drugs Multidisciplinary Digit Publishing Inst. 2019;17:140. https:\/\/doi.org\/10.3390\/md17030140.","journal-title":"Mar Drugs Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR23","doi-asserted-by":"publisher","first-page":"cwae046","DOI":"10.1093\/glycob\/cwae046","volume":"34","author":"LAA Damen","year":"2024","unstructured":"Damen LAA, Bui TP, van Wessel T, Li Y, Straten BF, Pampiermole R, et al. Identification of heparin-binding amino acid residues in antibody HS4C3 with the potential to design antibodies against heparan sulfate domains. Glycobiology. 2024;34:cwae046. https:\/\/doi.org\/10.1093\/glycob\/cwae046.","journal-title":"Glycobiology"},{"key":"4651_CR24","doi-asserted-by":"publisher","first-page":"12960","DOI":"10.1074\/jbc.273.21.12960","volume":"273","author":"TH van Kuppevelt","year":"1998","unstructured":"van Kuppevelt TH, Dennissen MABA, van Venrooij WJ, Hoet RMA, Veerkamp JH. Generation and Application of Type-specific Anti-Heparan Sulfate Antibodies Using Phage Display Technology: FURTHER EVIDENCE FOR HEPARAN SULFATE HETEROGENEITY IN THE KIDNEY *. J Biol Chem Elsevier. 1998;273:12960\u20136. https:\/\/doi.org\/10.1074\/jbc.273.21.12960.","journal-title":"J Biol Chem Elsevier"},{"key":"4651_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/jgm.677","volume":"7","author":"L Zhang","year":"2005","unstructured":"Zhang L, Leng Q, Mixson AJ. Alteration in the IL-2 signal peptide affects secretion of proteins in vitro and in vivo. J Gene Med. 2005;7:354\u201365. https:\/\/doi.org\/10.1002\/jgm.677.","journal-title":"J Gene Med"},{"key":"4651_CR26","doi-asserted-by":"publisher","first-page":"100035","DOI":"10.1016\/j.bbadva.2021.100035","volume":"2","author":"DSF Biard","year":"2022","unstructured":"Biard DSF, Jarray R, Rebergue N, Leteurtre F, Papy-Garcia D. APP deficiency and HTRA2 modulates PrPc proteostasis in human cancer cells. BBA Adv. 2022;2:100035. https:\/\/doi.org\/10.1016\/j.bbadva.2021.100035.","journal-title":"BBA Adv"},{"key":"4651_CR27","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1039\/D0NR06378A","volume":"13","author":"H Groult","year":"2021","unstructured":"Groult H, Carregal-Romero S, Castej\u00f3n D, Azkargorta M, Miguel-Coello A-B, Reddy Pulagam K, et al. Heparin length in the coating of extremely small iron oxide nanoparticles regulates in vivo theranostic applications. Nanoscale Royal Soc Chem. 2021;13:842\u201361. https:\/\/doi.org\/10.1039\/D0NR06378A.","journal-title":"Nanoscale Royal Soc Chem"},{"key":"4651_CR28","doi-asserted-by":"publisher","first-page":"2106570","DOI":"10.1002\/smll.202106570","volume":"18","author":"S Carregal-Romero","year":"2022","unstructured":"Carregal-Romero S, Miguel-Coello AB, Mart\u00ednez-Parra L, Mart\u00ed-Mateo Y, Hernansanz-Agust\u00edn P, Fern\u00e1ndez-Afonso Y, et al. Ultrasmall Manganese Ferrites for In Vivo Catalase Mimicking Activity and Multimodal Bioimaging. Small. 2022;18:2106570. https:\/\/doi.org\/10.1002\/smll.202106570.","journal-title":"Small"},{"key":"4651_CR29","doi-asserted-by":"publisher","first-page":"e3836","DOI":"10.17795\/ijcp-3836","volume":"9","author":"M Jazzara","year":"2016","unstructured":"Jazzara M, Ghannam A, Soukkarieh C, Murad H. Anti-Proliferative Activity of \u03bb-Carrageenan Through the Induction of Apoptosis in Human Breast Cancer Cells. Iran J Cancer Prev. 2016;9:e3836. https:\/\/doi.org\/10.17795\/ijcp-3836.","journal-title":"Iran J Cancer Prev"},{"key":"4651_CR30","unstructured":"Manseur C, Conception. et optimisation d\u2019oligosaccharides de lambda-carragh\u00e9nanes et de fucoidanes \u00e0 vis\u00e9e anti-canc\u00e9reuse [Internet] [Theses]. Universit\u00e9 de La Rochelle; 2024 [cited 2025 Dec 5]. https:\/\/theses.hal.science\/tel-05088009. Accessed 5 Dec 2025."},{"key":"4651_CR31","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/jcmm.13110","volume":"21","author":"S Salatin","year":"2017","unstructured":"Salatin S, Yari Khosroushahi A. Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles. J Cell Mol Med. 2017;21:1668\u201386. https:\/\/doi.org\/10.1111\/jcmm.13110.","journal-title":"J Cell Mol Med"},{"key":"4651_CR32","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1182\/blood-2007-09-112474","volume":"111","author":"M Narazaki","year":"2008","unstructured":"Narazaki M, Segarra M, Tosato G. Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. Blood. 2008;111:4126\u201336. https:\/\/doi.org\/10.1182\/blood-2007-09-112474.","journal-title":"Blood"},{"key":"4651_CR33","doi-asserted-by":"publisher","unstructured":"Manescu V, Paltanea G, Antoniac I, Vasilescu M, editors. Magnetic Nanoparticles Used in Oncology. Materials. Multidisciplinary Digital Publishing Institute; 2021;14:5948. https:\/\/doi.org\/10.3390\/ma14205948","DOI":"10.3390\/ma14205948"},{"key":"4651_CR34","doi-asserted-by":"publisher","unstructured":"Chen P, Bornhorst JB, Aschner M. Manganese metabolism in humans. Front Biosci-Landmark. IMR Press; Invalid date;23:1655\u201379. https:\/\/doi.org\/10.2741\/4665","DOI":"10.2741\/4665"},{"key":"4651_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/md16080277","volume":"16","author":"X Chen","year":"2018","unstructured":"Chen X, Zhao X, Gao Y, Yin J, Bai M, Wang F. Green Synthesis of Gold Nanoparticles Using Carrageenan Oligosaccharide and Their In Vitro Antitumor Activity. Mar Drugs Multidisciplinary Digit Publishing Inst. 2018;16:277. https:\/\/doi.org\/10.3390\/md16080277.","journal-title":"Mar Drugs Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","volume":"25","author":"F Klemm","year":"2015","unstructured":"Klemm F, Joyce JA. Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol Elsevier. 2015;25:198\u2013213. https:\/\/doi.org\/10.1016\/j.tcb.2014.11.006.","journal-title":"Trends Cell Biol Elsevier"},{"key":"4651_CR37","doi-asserted-by":"publisher","first-page":"101626","DOI":"10.1016\/j.mtbio.2025.101626","volume":"31","author":"S Karimi","year":"2025","unstructured":"Karimi S, Bakhshali R, Bolandi S, Zahed Z, Mojtaba Zadeh SS, Kaveh Zenjanab M, et al. For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy. Mater Today Bio. 2025;31:101626. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101626.","journal-title":"Mater Today Bio"},{"key":"4651_CR38","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.exphem.2016.08.006","volume":"44","author":"B Heyman","year":"2016","unstructured":"Heyman B, Yang Y. Mechanisms of Heparanase Inhibitors in Cancer Therapy. Exp Hematol. 2016;44:1002\u201312. https:\/\/doi.org\/10.1016\/j.exphem.2016.08.006.","journal-title":"Exp Hematol"},{"key":"4651_CR39","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/cells7120236","volume":"7","author":"V Masola","year":"2018","unstructured":"Masola V, Bellin G, Gambaro G, Onisto M, Heparanase. A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events. Cells Multidisciplinary Digit Publishing Inst. 2018;7:236. https:\/\/doi.org\/10.3390\/cells7120236.","journal-title":"Cells Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcancer.2019.07.014","volume":"62","author":"V Masola","year":"2020","unstructured":"Masola V, Zaza G, Gambaro G, Franchi M, Onisto M. Role of heparanase in tumor progression: Molecular aspects and therapeutic options. Semin Cancer Biol. 2020;62:86\u201398. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.014.","journal-title":"Semin Cancer Biol"},{"key":"4651_CR41","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.3390\/molecules23112915","volume":"23","author":"C Lanzi","year":"2018","unstructured":"Lanzi C, Cassinelli G. Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity. Molecules Multidisciplinary Digit Publishing Inst. 2018;23:2915. https:\/\/doi.org\/10.3390\/molecules23112915.","journal-title":"Molecules Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR42","doi-asserted-by":"publisher","first-page":"112221","DOI":"10.1016\/j.ejmech.2020.112221","volume":"193","author":"K Fu","year":"2020","unstructured":"Fu K, Bai Z, Chen L, Ye W, Wang M, Hu J, et al. Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances. Eur J Med Chem. 2020;193:112221. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112221.","journal-title":"Eur J Med Chem"},{"key":"4651_CR43","first-page":"3433","volume":"59","author":"CR Parish","year":"1999","unstructured":"Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB. Identification of Sulfated Oligosaccharide-based Inhibitors of Tumor Growth and Metastasis Using Novel in Vitro Assays for Angiogenesis and Heparanase Activity1. Cancer Res. 1999;59:3433\u201341.","journal-title":"Cancer Res"},{"key":"4651_CR44","first-page":"1207","volume":"2","author":"JA Low","year":"1996","unstructured":"Low JA, Johnson MD, Bone EA, Dickson RB. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. Clin Cancer Res. 1996;2:1207\u201314.","journal-title":"Clin Cancer Res"},{"key":"4651_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/187152008783330824","volume":"8","author":"J-P Li","year":"2008","unstructured":"Li J-P, Heparin. Heparan Sulfate and Heparanase in Cancer: Remedy for Metastasis? Anticancer Agents Med Chem. 2008;8:64\u201376. https:\/\/doi.org\/10.2174\/187152008783330824.","journal-title":"Anticancer Agents Med Chem"},{"key":"4651_CR46","doi-asserted-by":"publisher","first-page":"9661","DOI":"10.1016\/S0021-9258(18)92871-1","volume":"266","author":"M Nakajima","year":"1991","unstructured":"Nakajima M, DeChavigny A, Johnson CE, Hamada J, Stein CA, Nicolson GL. Suramin. A potent inhibitor of melanoma heparanase and invasion. J Biol Chem. 1991;266:9661\u20136. https:\/\/doi.org\/10.1016\/S0021-9258(18)92871-1.","journal-title":"J Biol Chem"},{"key":"4651_CR47","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/S0049-3848(07)70139-1","volume":"120","author":"I Vlodavsky","year":"2007","unstructured":"Vlodavsky I, Ilan N, Nadir Y, Brenner B, Katz B-Z, Naggi A, et al. Heparanase, heparin and the coagulation system in cancer progression. Thromb Res. 2007;120:S112\u201320. https:\/\/doi.org\/10.1016\/S0049-3848(07)70139-1.","journal-title":"Thromb Res"},{"key":"4651_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/978-3-030-34521-1_20","volume-title":"Heparanase Basic Res Clin Appl [Internet]","author":"G Cassinelli","year":"2020","unstructured":"Cassinelli G, Torri G, Naggi A. Non-Anticoagulant Heparins as Heparanase Inhibitors. In: Vlodavsky I, Sanderson RD, Ilan N, editors. Heparanase Basic Res Clin Appl [Internet]. Cham: Springer International Publishing; 2020. pp. 493\u2013522. [cited 2025 May 2]. https:\/\/doi.org\/10.1007\/978-3-030-34521-1_20."},{"key":"4651_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11302-020-09760-9","volume":"17","author":"JB de Ara\u00fajo","year":"2021","unstructured":"de Ara\u00fajo JB, Kerkhoff VV, de Oliveira Maciel SFV, de Resende e Silva DT. Targeting the purinergic pathway in breast cancer and its therapeutic applications. Purinergic Signal. 2021;17:179\u2013200. https:\/\/doi.org\/10.1007\/s11302-020-09760-9.","journal-title":"Purinergic Signal"},{"key":"4651_CR50","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.actbio.2018.12.010","volume":"84","author":"B Cheng","year":"2019","unstructured":"Cheng B, Gao F, Maissy E, Xu P. Repurposing suramin for the treatment of breast cancer lung metastasis with glycol chitosan-based nanoparticles. Acta Biomater. 2019;84:378\u201390. https:\/\/doi.org\/10.1016\/j.actbio.2018.12.010.","journal-title":"Acta Biomater"},{"key":"4651_CR51","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/md19100546","volume":"19","author":"R Cousin","year":"2021","unstructured":"Cousin R, Groult H, Manseur C, Ferru-Cl\u00e9ment R, Gani M, Havret R, et al. A Marine \u03bb-Oligocarrageenan Inhibits Migratory and Invasive Ability of MDA-MB-231 Human Breast Cancer Cells through Actions on Heparanase Metabolism and MMP-14\/MMP-2 Axis. Mar Drugs Multidisciplinary Digit Publishing Inst. 2021;19:546. https:\/\/doi.org\/10.3390\/md19100546.","journal-title":"Mar Drugs Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1166487","author":"SU Khan","year":"2023","unstructured":"Khan SU, Khan MU, Azhar Ud Din M, Khan IM, Khan MI, Bungau S, et al. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy. Front Immunol [Internet] Front. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1166487. [cited 2025 May 2];14.","journal-title":"Front Immunol [Internet] Front"},{"key":"4651_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. Nat Publishing Group. 2023;8:1\u201335. https:\/\/doi.org\/10.1038\/s41392-023-01452-1.","journal-title":"Nat Publishing Group"},{"key":"4651_CR54","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/cells14100741","volume":"14","author":"AF Saeed","year":"2025","unstructured":"Saeed AF. Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy. Cells. Multidisciplinary Digit Publishing Inst. 2025;14:741. https:\/\/doi.org\/10.3390\/cells14100741.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR55","doi-asserted-by":"publisher","unstructured":"Mulens-Arias V, Rojas JM, Barber DF. The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment. Front Immunol [Internet]. 2021 [cited 2023 May 20];12. https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2021.693709. Accessed 20 May 2023.","DOI":"10.3389\/fimmu.2021.693709"},{"key":"4651_CR56","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1021\/acsnano.8b08785","volume":"13","author":"J Kim","year":"2019","unstructured":"Kim J, Kim HY, Song SY, Go S, Sohn HS, Baik S, et al. Synergistic Oxygen Generation and Reactive Oxygen Species Scavenging by Manganese Ferrite\/Ceria Co-decorated Nanoparticles for Rheumatoid Arthritis Treatment. ACS Nano Am Chem Soc. 2019;13:3206\u201317. https:\/\/doi.org\/10.1021\/acsnano.8b08785.","journal-title":"ACS Nano Am Chem Soc"},{"key":"4651_CR57","doi-asserted-by":"publisher","first-page":"13375","DOI":"10.1021\/acsami.4c18570","volume":"17","author":"H Chen","year":"2025","unstructured":"Chen H, Wang D, Liu J, Chen J, Hu Y, Ni Y. Augmenting Antitumor Immune Effects through the Coactivation of cGAS-STING and NF-\u03baB Crosstalk in Dendritic Cells and Macrophages by Engineered Manganese Ferrite Nanohybrids. ACS Appl Mater Interfaces Am Chem Soc. 2025;17:13375\u201390. https:\/\/doi.org\/10.1021\/acsami.4c18570.","journal-title":"ACS Appl Mater Interfaces Am Chem Soc"},{"key":"4651_CR58","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1021\/jacs.4c14700","volume":"147","author":"T Guan","year":"2025","unstructured":"Guan T, Chen Z, Wang X, Gao S, Lu X, Li Y, et al. Harnessing Mn2\u2009+\u2009Ions and Antitumor Peptides: A Robust Hydrogel for Enhanced Tumor Immunotherapy. J Am Chem Soc Am Chem Soc. 2025;147:6523\u201335. https:\/\/doi.org\/10.1021\/jacs.4c14700.","journal-title":"J Am Chem Soc Am Chem Soc"},{"key":"4651_CR59","doi-asserted-by":"publisher","unstructured":"Hu G, Guo M, Xu J, Wu F, Fan J, Huang Q et al. Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation. Front Immunol [Internet]. Frontiers; 2019 [cited 2025 May 2];10. https:\/\/doi.org\/10.3389\/fimmu.2019.01998","DOI":"10.3389\/fimmu.2019.01998"},{"key":"4651_CR60","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4161\/onci.19456","volume":"1","author":"H Daldrup-Link","year":"2012","unstructured":"Daldrup-Link H, Coussens LM. MR imaging of tumor-associated macrophages. OncoImmunology Taylor Francis. 2012;1:507\u20139. https:\/\/doi.org\/10.4161\/onci.19456.","journal-title":"OncoImmunology Taylor Francis"},{"key":"4651_CR61","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.3390\/cells10113194","volume":"10","author":"K Kashfi","year":"2021","unstructured":"Kashfi K, Kannikal J, Nath N. Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO. Cells. Multidisciplinary Digit Publishing Inst. 2021;10:3194. https:\/\/doi.org\/10.3390\/cells10113194.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"4651_CR62","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/cbin.12226","volume":"48","author":"S Malik","year":"2024","unstructured":"Malik S, Sureka N, Ahuja S, Aden D, Zaheer S, Zaheer S. Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire. Cell Biol Int. 2024;48:1406\u201349. https:\/\/doi.org\/10.1002\/cbin.12226.","journal-title":"Cell Biol Int"},{"key":"4651_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.730672","author":"P-L Krauss","year":"2021","unstructured":"Krauss P-L, Pfeiffenberger M, Damerau A, Buttgereit T, Chen Y, Gaber T, et al. Production of IL-6 and Phagocytosis Are the Most Resilient Immune Functions in Metabolically Compromised Human Monocytes. Front Immunol [Internet] Front. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.730672. [cited 2025 May 2];12.","journal-title":"Front Immunol [Internet] Front"},{"key":"4651_CR64","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.nano.2018.01.014","volume":"14","author":"A Shah","year":"2018","unstructured":"Shah A, Dobrovolskaia MA. Immunological Effects of Iron Oxide Nanoparticles and Iron-based Complex Drug Formulations: Therapeutic Benefits, Toxicity, Mechanistic Insights, and Translational Considerations. Nanomed Nanotechnol Biol Med. 2018;14:977\u201390. https:\/\/doi.org\/10.1016\/j.nano.2018.01.014.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"4651_CR65","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s11427-011-4215-5","volume":"54","author":"J Gu","year":"2011","unstructured":"Gu J, Xu H, Han Y, Dai W, Hao W, Wang C, et al. The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell. Sci China Life Sci. 2011;54:793\u2013805. https:\/\/doi.org\/10.1007\/s11427-011-4215-5.","journal-title":"Sci China Life Sci"},{"key":"4651_CR66","doi-asserted-by":"publisher","unstructured":"Zhang W, Cao S, Liang S, Tan CH, Luo B, Xu X et al. Differently Charged Super-Paramagnetic Iron Oxide Nanoparticles Preferentially Induced M1-Like Phenotype of Macrophages. Front Bioeng Biotechnol [Internet]. 2020 [cited 2023 May 20];8. https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fbioe.2020.00537. Accessed 20 May 2023.","DOI":"10.3389\/fbioe.2020.00537"},{"key":"4651_CR67","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1021\/acsnano.9b01383","volume":"13","author":"W Poon","year":"2019","unstructured":"Poon W, Zhang Y-N, Ouyang B, Kingston BR, Wu JLY, Wilhelm S, et al. Elimination Pathways of Nanoparticles. ACS Nano. 2019;13:5785\u201398. https:\/\/doi.org\/10.1021\/acsnano.9b01383.","journal-title":"ACS Nano"},{"key":"4651_CR68","doi-asserted-by":"publisher","first-page":"116930","DOI":"10.1016\/j.biopha.2024.116930","volume":"177","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang M, Ji C, Liu X, Gu B, Dong T. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials. Biomed Pharmacother. 2024;177:116930. https:\/\/doi.org\/10.1016\/j.biopha.2024.116930.","journal-title":"Biomed Pharmacother"},{"key":"4651_CR69","doi-asserted-by":"publisher","first-page":"16554","DOI":"10.1038\/s41598-020-73624-w","volume":"10","author":"M Oshi","year":"2020","unstructured":"Oshi M, Tokumaru Y, Asaoka M, Yan L, Satyananda V, Matsuyama R, et al. M1 Macrophage and M1\/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer. Sci Rep Nat Publishing Group. 2020;10:16554. https:\/\/doi.org\/10.1038\/s41598-020-73624-w.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"4651_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1441820","author":"M Stavrou","year":"2024","unstructured":"Stavrou M, Constantinidou A. Tumor associated macrophages in breast cancer progression: implications and clinical relevance. Front Immunol [Internet] Front. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1441820. [cited 2025 Dec 15];15.","journal-title":"Front Immunol [Internet] Front"},{"key":"4651_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10811-010-9536-4","volume":"23","author":"H Yuan","year":"2011","unstructured":"Yuan H, Song J, Li X, Li N, Liu S. Enhanced immunostimulatory and antitumor activity of different derivatives of \u03ba-carrageenan oligosaccharides from Kappaphycus striatum. J Appl Phycol. 2011;23:59\u201365. https:\/\/doi.org\/10.1007\/s10811-010-9536-4.","journal-title":"J Appl Phycol"},{"key":"4651_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.phrs.2003.12.002","volume":"50","author":"G Zhou","year":"2004","unstructured":"Zhou G, Sun Y, Xin H, Zhang Y, Li Z, Xu Z. In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus. Pharmacol Res. 2004;50:47\u201353. https:\/\/doi.org\/10.1016\/j.phrs.2003.12.002.","journal-title":"Pharmacol Res"},{"key":"4651_CR73","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.canlet.2005.11.032","volume":"243","author":"H Yuan","year":"2006","unstructured":"Yuan H, Song J, Li X, Li N, Dai J. Immunomodulation and antitumor activity of \u03ba-carrageenan oligosaccharides. Cancer Lett. 2006;243:228\u201334. https:\/\/doi.org\/10.1016\/j.canlet.2005.11.032.","journal-title":"Cancer Lett"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04651-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T01:28:19Z","timestamp":1787189299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04651-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,14]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4651"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04651-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,14]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed in accordance with the Spanish policy for animal protection (RD53\/2013), which meets the requirements of Directive 2010\/63\/UE. The 7T procedures were approved by the Ethical Committee of the CIC biomaGUNE and authorized by the local authorities (PRO-AES-SS-225). The in vivo work was carried out at the ReDIB ICTS infrastructure at CIC biomaGUNE, Ministry of Science, Innovation and Universities (MCIU)","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors disclose the use of AI-based tools for language editing and bibliographic search assistance. These tools were not used to generate scientific content, analyze data, draw conclusions, edit figures or the graphical abstract. The authors ensured human oversight and control whenever AI-based tools were used for language editing, including verification of accuracy, comprehensiveness, and impartiality. Responsibility for the manuscript remains entirely with the authors.","order":3,"name":"Ethics","label":"Declaration statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"786"}}